🔎 Trials Near Me

Beranda › Neuropati Sensorik dan Otonom Herediter › Oregon

Uji klinis Neuropati Sensorik dan Otonom Herediter di Oregon

6 studi untuk Neuropati Sensorik dan Otonom Herediter mencari peserta di lokasi di Oregon.

Kota di Oregon

Teks studi resmi (Bahasa Inggris)

Carboplatin or Olaparib for BRcA Deficient Prostate Cancer

  • VA Portland Health Care System, Portland, OR, Portland
Menerima pesertaFase 2
Usia 18 ke atas · Pria · Diperbarui 17 Sep 2026 · NCT04038502

A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)

  • Bend Memorial Clinic, Bend
Menerima pesertaFase 2
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 10 Agu 2026 · NCT07175038

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

  • Oregon Health & Science University, Portland
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Jul 2026 · NCT04657068

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

  • Providence Cancer Institute Franz Clinic, Portland
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 7 Jul 2026 · NCT05768139

Sapanisertib and Serabelisib (PIKTOR) in Various Combinations in Patients With HR+/HER2- Advanced/Metastatic Breast Cancer

  • Oncology Associates of Oregon, Springfield
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Jul 2026 · NCT07558733

Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer

  • Oncology Associates of Oregon, P.C., Eugene
  • Northwest Cancer Specialists, P.C., Portland
Menerima pesertaFase 2
Usia 18 ke atas · Wanita · Diperbarui 24 Des 2025 · NCT06463028

Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.